T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Citizens Financial Group
CFG
$31.1B
| $16.4M | ﹤0.01% |
870,641
+68,326
| +9% | +$2.23M |
|
1127
Iron Mountain
IRM
$37B
| $16.3M | ﹤0.01% |
685,667
-112,269
| -14% | -$3.4M |
|
1128
Insteel Industries
IIIN
$635M
| $16.3M | ﹤0.01% |
1,230,221
+23,106
| +2% | +$458K |
|
1129
Principal Financial Group
PFG
$24.4B
| $16.3M | ﹤0.01% |
518,934
+41,660
| +9% | +$1.97M |
|
1130
Viatris
VTRS
$18.5B
| $16.2M | ﹤0.01% |
1,089,706
+116,555
| +12% | +$2.23M |
|
1131
Scholar Rock
SRRK
$6.55B
| $16.2M | ﹤0.01% |
1,336,143
+78,612
| +6% | +$1.06M |
|
1132
Robert Half
RHI
$4.25B
| $16.2M | ﹤0.01% |
428,525
+27,895
| +7% | +$1.51M |
|
1133
Expedia Group
EXPE
$39.1B
| $16M | ﹤0.01% |
285,216
+22,269
| +8% | +$2.14M |
|
1134
Urban Edge Properties
UE
$2.75B
| $16M | ﹤0.01% |
1,819,884
-118,856
| -6% | -$1.95M |
|
1135
Everest Group
EG
$13.9B
| $16M | ﹤0.01% |
83,073
+6,406
| +8% | +$1.64M |
|
1136
Kosmos Energy
KOS
$1.51B
| $16M | ﹤0.01% |
17,824,938
+3,016,383
| +20% | +$12M |
|
1137
Diageo
DEO
$52.8B
| $15.9M | ﹤0.01% |
124,924
+9,670
| +8% | +$1.45M |
|
1138
TechnipFMC
FTI
$29.5B
| $15.8M | ﹤0.01% |
3,150,110
+2,075,431
| +193% | +$22.8M |
|
|
ALEX
1139
DELISTED
Alexander & Baldwin
ALEX
| $15.8M | ﹤0.01% |
1,403,849
-2,253,406
| -62% | -$42.2M |
|
1140
Moderna
MRNA
$25.4B
| $15.7M | ﹤0.01% |
525,643
-603,854
| -53% | -$13.9M |
|
1141
RGC Resources
RGCO
$225M
| $15.7M | ﹤0.01% |
543,885
+22,964
| +4% | +$623K |
|
1142
ADT
ADT
$5.34B
| $15.7M | ﹤0.01% |
3,640,957
+70,763
| +2% | +$428K |
|
1143
Graphic Packaging
GPK
$3.46B
| $15.6M | ﹤0.01% |
1,282,286
+992,135
| +342% | +$14.6M |
|
1144
Western Union
WU
$2.34B
| $15.6M | ﹤0.01% |
858,027
+82,185
| +11% | +$2.02M |
|
1145
Southern First Bancshares
SFST
$607M
| $15.5M | ﹤0.01% |
546,753
+15,484
| +3% | +$576K |
|
1146
Saga Communications
SGA
$64.6M
| $15.4M | ﹤0.01% |
561,241
-16,379
| -3% | -$482K |
|
1147
Natera
NTRA
$45.5B
| $15.4M | ﹤0.01% |
514,899
-24,844
| -5% | -$830K |
|
1148
Texas Pacific Land
TPL
$23.6B
| $15.4M | ﹤0.01% |
+363,816
| New | +$26.6M |
|
1149
CryoPort
CYRX
$766M
| $15.3M | ﹤0.01% |
897,295
+5,509
| +0.6% | +$96.5K |
|
|
VERT.U
1150
DELISTED
Vertiv Holdings Co Units, each consisting of one share of Class A common stock and one-third of one
VERT.U
| $15.3M | ﹤0.01% |
+1,777,754
| New | +$20.2M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.